Biosyent (RX) Cash flow

53 Followers

Biosyent Cash Flow

TSE:RX's free cash flow for Q4 2025 was C$3.80M. For the 2025 fiscal year, TSE:RX's free cash flow was decreased by C$5.57M and operating cash flow was C$3.82M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	C$ 9.62M	C$ 8.66M	C$ 5.05M	C$ 4.95M	C$ 4.67M
Investing Cash Flow	C$ 3.48M	C$ 3.29M	C$ 883.85K	C$ -10.79M	C$ -4.84M
Financing Cash Flow	C$ -3.41M	C$ -7.83M	C$ -5.78M	C$ -4.37M	C$ -2.08M
End Cash Position	C$ 20.29M	C$ 12.11M	C$ 7.98M	C$ 7.86M	C$ 18.04M
Free Cash Flow	C$ 9.57M	C$ 3.99M	C$ 4.88M	C$ 4.43M	C$ 4.58M

Currency in CAD